– Testocreme® is a new testosterone formulation– 505(b)(2) regulatory pathway for clinical development– Phase I clinical trial to evaluate
Following Phase I Clinical Study, Testocreme® will seek a strategic partner or potential acquirer.
Testosterone is an approved and marketed drug
The statements enclosed herein have not been evaluated by the Food and Drug Administration.
Copyright © Testocreme®, Inc. All rights reserved.